In the multivariable logistic regression on the whole cohort, chemoimmunotherapy (OR, 3·42; 95% CI, 1·04–11·21; P = 0.04) was associated with a significantly lower rate of seroconversion, while immunotherapy (OR, 4·23; 95% CI, 0·96–18·57; P = 0·06) was of borderline significance (Fig 1C ).
← all excerpts
COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies.
1
—
—